Glatiramer acetate slows disability progression - results from a 6-year analysis of the UK Risk Sharing Scheme
dc.contributor.author | Giovannoni, G | en_US |
dc.contributor.author | Brex, P | en_US |
dc.contributor.author | Sumra, M | en_US |
dc.contributor.author | Walters, E | en_US |
dc.contributor.author | Schmierer, K | en_US |
dc.date.accessioned | 2016-02-17T11:03:08Z | |
dc.date.issued | 2015-09 | en_US |
dc.date.submitted | 2016-02-15T22:19:38.853Z | |
dc.identifier.issn | 1352-4585 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/11118 | |
dc.format.extent | 800 - 801 | en_US |
dc.title | Glatiramer acetate slows disability progression - results from a 6-year analysis of the UK Risk Sharing Scheme | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729402389&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 21 | en_US |